Summary

Steve Erickson is an Associate Professor in the Department of Clinical Pharmcy at the University of Michigan College of Pharmacy.  Dr. Erickson received his Bachelors in Pharmacy from Ferris State College in 1980 and a PharmD from Wayne State University in 1984.

Wayne State University Developmental Disabilities Institute
     Faculty Affiliate, January 2012 to present

Feature Story
Medication Management Podcast

Managing medications is not always easy. In this episode, Clinical Pharmacist Dr. Steven Erickson talks about how to make the process efficient and safe for people with disabilities and their caregivers.

Read More

Research Interests

  • Development and assessment of innovative pharmacy services to improve the outcomes of appropriate use of medications

  • Assessment of medication use processes to ensure the safe and effective use of medications by people with intellectual and developmental disabilities

  • Study of patient, disease, and treatment factors associated with health related quality of life, patient-perceived functional status, and measured functional status and performance

  • Study of patient, disease, and treatment factors associated with health related quality of life, patient-perceived functional status, and measured functional status and performance

  • Study of the association between geographic, neighborhood, and spatial factors with medication adherence and persistence

Awards

  • 2023 Innovation and Excellence in Interprofessional Education, UM Center for Interprofessional Education
  • 2023 Consultant Pharmacist of the Year, Michigan Pharmacists Association
  • 2022 Fellow of the American Association on Intellectual and Developmental Disabilities, American Association on Intellectual and Developmental Disabilities
  • 2018 Teaching Excellence Award, College of Pharmacy
  • 2018 P3 Student Appreciation Award , Phi Delta Chi COP
  • 2015 P3 Pharmacy Student Class Teacher Appreciation Award, Phi Delta Chi
  • 2015 Certificate of Appreciation, James T Neubacher Award Committee

Selected Publications

  • Erickson SR, Jones J, Gallus K, Houseworth J, Esler A. Potential drug interactions in medication regimens of adults who have intellectual and developmental disabilities.  Journal of Developmental and Physical Disabilities, 2021; doi.org/10.1007/s10882-021-09824-7

  • Erickson SR. In-home Comprehensive Medication Reviews for Adults with Intellectual or Developmental Disability: A Pilot Study.  Journal of the American Pharmacists Association 2020;60(6):e279-e291. doi.org/10.1016/j.japh.2020.03.019

  • Erickson SR, Basu T, Dorsch M, Kamdar N.  Disparities in the use of guideline-based pharmacotherapy exist for atherosclerotic cardiovascular disease and heart failure patients who have intellectual/developmental disabilities in a commercially insured database.  Annals of Pharmacotherapy, 2020;54(10):958-966.  doi.org/10.1177/1060028020916842

  • Erickson SR, Kamdar, N, Wu, CH.  Adverse Medication Events Related to Hospitalization in the U.S.: A comparison between Adults with Intellectual/Developmental Disabilities and those Without.  Am J Intellect Dev Disabil 2020;125:37-48. doi:10.1352/1944-7558-125.1.37

  • Erickson SR, Yang Y.  Hassles with medication management perceived by caregivers of adults who have intellectual/developmental disabilities.  International Journal of Clinical Pharmacy, 2019 Feb;41(1):131-140. doi: 10.1007/s11096-018-0771-0.

  • Erickson SR, Juncaj S, Buckley C.  Family caregivers of people who have intellectual/ developmental disabilities and asthma: Caregiver knowledge of asthma self-management concepts – A pilot study.  British Journal of Learning Disabilities.  2018;46 (3), 172-181

  • Erickson SR, Nicaj D, Barron S.  Complexity of medication regimens of people with intellectual/developmental disabilities.  Journal of Intellectual & Developmental Disability. 2017. doi:org/10.3109/13668250.2017.1350836

  • Erickson SR, Spoutz P, Dorsch M, Bleske B. Cardiovascular risk and treatment for adults with intellectual or developmental disabilities.  International Journal of Cardiology, 2016. 221:371-375.

  • Erickson SR, Kornexl K.  Blood pressure screening, control, and treatment for patients with developmental disabilities in general medicine practices.  Journal of Pharmacy Technology, 2016;32:234-239.  Doi: 10.1177/8755122516663219

  • Erickson SR, Salgado TM, Tan X.  Issues in the medication management process in people who have intellectual/developmental disability: a qualitative study of the caregivers’ perspective.  Intellectual and Developmental Disabilities. 2016;54:4412-426. Doi:10.1352/1934-9556-54.6.412

  • Erickson SR, LeRoy B.  Health literacy and medication administration performance by caregivers of adults with developmental disabilities. J Am Pharm Assoc 2015:55:169-177

  • Patel I, Erickson SR, Caldwell CH, Woolford SJ, Bagozzi RP, Chang J, Balkrishnan R. Predictors of medication adherence and persistence in Medicaid enrollees with developmental disabilities and type 2 diabetes. Research in Social and Administrative Pharmacy 2015; 12:592-603. doi:10.1016/j.sapharm.2015.09.008